BFLY News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

BF

Mkt Cap

$1.93B

Volume

4.16M

Next Earnings

October 29th

Loading chart

BF

BFLYButterfly Network, Inc.

BFLY

Pay with—

Available Balance0.00

BF

Mkt Cap

$1.93B

Volume

4.16M

Next Earnings

October 29th

Chart Financials Earnings News About Insider Filings

Ultrasound AI Market Size to Surge to USD 22.03 Billion by 2035 at a CAGR of 26.62% – SNS InsiderThe global Ultrasound AI market is projected to grow from USD 2.09 billion in 2025 to USD 22.03 billion by 2035, with a CAGR of 26.62%. Growth is driven by deep learning advancements, point-of-care imaging adoption, and sonographer shortages. North America leads with 45.54% market share, while Asia-Pacific shows the fastest growth at 28.57% CAGR. Hardware dominates at 48% market share, with software as the fastest-growing segment.GlobeNewswire Inc. · Sep 17, 2026

3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber RiskThe Medical Information Systems industry is positioned for growth driven by AI integration in healthcare, with a projected 39.7% CAGR through 2031. However, rising cybersecurity threats pose significant risks. Three stocks—Inspire Medical Systems, American Well, and Butterfly Network—are well-positioned to benefit from demand for AI-powered solutions and digital health platforms, though the industry has underperformed the broader market over the past year.Zacks Investment Research · Sep 11, 2026

Butterfly Network Director Phanstiel Buys $1.0 Million in Stock. Is This a Sign Investors Should Also Buy?Butterfly Network director Louise S. Phanstiel purchased 115,200 shares worth $1.0 million at $8.68 per share, increasing her total beneficial ownership to 691,413 shares (0.26% of the company). The insider purchase is viewed as a bullish signal, particularly given Phanstiel's healthcare expertise. Analysts project 19% revenue growth for the current fiscal year and expect the company to double its 2026 revenue by 2028 while narrowing net losses.The Motley Fool · Aug 21, 2026

Butterfly Network Founder Rothberg Sells Another 660,000 Shares. Should Investors Worry?Butterfly Network founder Jonathan Rothberg sold approximately 660,000 shares (~$4.3 million) on July 22, 2026, under a pre-scheduled Rule 10b5-1 trading plan for estate planning purposes. While the sale was pre-planned, analysts note it's concerning timing given the stock's 250% surge over the past year and multiple recent insider sales. Despite positive analyst outlooks for 2026 revenue growth of 22%, investors are advised to reconsider their investment thesis given the founder's share liquidation near five-year highs.The Motley Fool · Jul 27, 2026

Butterfly Network Founder Jonathan Rothberg Sells Nearly $21 Million in Shares. What Does This Mean for Investors?Butterfly Network founder Jonathan Rothberg sold approximately 3.1 million Class B shares worth $20.7 million at $6.64 per share through a pre-planned Rule 10b5-1 trading plan established for estate planning purposes. While the sale was scheduled in advance, analysts note it could signal reduced confidence given the stock's 263% rally over 12 months. Rothberg retains 19.7 million shares indirectly through various trusts and entities.The Motley Fool · Jul 22, 2026

Butterfly Network Insider Sheds 399K Shares — This Stock May Be Ready to Take FlightButterfly Network's Chief Business Officer Steve Cashman sold 399,461 shares (19.68% of his direct holdings) for approximately $1.9 million in June 2026. The sale marks his largest single open-market transaction to date. While the stock has surged 291.8% over the past year, the analyst suggests the recent rally may have already priced in future growth, particularly from a new Midjourney licensing deal worth $10 million annually plus milestone payments. The core ultrasound business shows solid but unspectacular growth (19-25%), creating concentration risk around the single licensing relationship.The Motley Fool · Jul 5, 2026

16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart GapVentripoint Diagnostics announced support for the newly formed Global Congenital Heart Disease Alliance (GCHDA), positioning its AI-powered VMS+ cardiac imaging platform to address a critical global healthcare gap. With 16 million people living with congenital heart disease and over 90% of children in lower-income countries lacking timely care, Ventripoint's vendor-agnostic technology delivers MRI-level accuracy from standard echocardiograms. The alliance will fund and place four VMS+ units, signaling commercial validation in a rapidly growing AI cardiology market projected to reach $14.2 billion by the mid-2030s.Benzinga · Jun 16, 2026

Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial FrontsVentripoint Diagnostics has achieved multiple validation milestones in early 2026, including submitting its VMS+ 4.0 system to China's NMPA for expedited review, exhibiting at Europe's largest congenital cardiology conference, and establishing commercial partnerships for hospital deployment. The company is capitalizing on a shifting procurement environment where hospitals now demand economic proof alongside clinical accuracy for AI cardiac imaging solutions.Benzinga · May 19, 2026

Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve OutcomesHospital networks are increasingly adopting AI-enhanced cardiac imaging technologies to reduce costs and improve patient outcomes. The AI medical imaging market is projected to reach nearly $20 billion by 2033, with echocardiography expected to grow to $2.64 billion by 2030. Key players including VentriPoint Diagnostics, Butterfly Network, Tempus AI, RadNet, and GE HealthCare are expanding their deployments across healthcare systems, with several reporting strong revenue growth and positive financial metrics.Benzinga · Mar 3, 2026

Bedside Breakthrough: AI Brings MRI-Precision to Every ClinicAI-driven clinical intelligence is transforming medical imaging, with point-of-care diagnostics projected to reach $70.92 billion by 2032. The CMS ACCESS Model launching in July 2026 will reward outcome-based care, driving adoption of software-defined imaging platforms. Key players including VentriPoint Diagnostics, Butterfly Network, Hyperfine, Hologic, and GE HealthCare are advancing portable, AI-powered diagnostic solutions that deliver hospital-grade precision at the bedside, reducing facility overhead while improving patient outcomes.Benzinga · Jan 16, 2026

to start trading

BF

BFLYButterfly Network, Inc.

BFLY

Pay with—

Available Balance0.00

Your PositionYou don't own any BFLY yet.

Related Tickers

Earnings